
Leigh C. Maier
Examiner (ID: 12110, Phone: (571)272-0656 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1614, 1621, 1693 |
| Total Applications | 1395 |
| Issued Applications | 727 |
| Pending Applications | 80 |
| Abandoned Applications | 594 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13548787
[patent_doc_number] => 20180325941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => COMPOSITION FOR REDUCING ABSORPTION OF DIETARY FAT
[patent_app_type] => utility
[patent_app_number] => 15/977840
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15977840
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/977840 | COMPOSITION FOR REDUCING ABSORPTION OF DIETARY FAT | May 10, 2018 | Abandoned |
Array
(
[id] => 13533413
[patent_doc_number] => 20180318249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => COMPOSITION CONTAINING CYCLODEXTRIN AND BUSULFAN
[patent_app_type] => utility
[patent_app_number] => 15/969561
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15969561
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/969561 | COMPOSITION CONTAINING CYCLODEXTRIN AND BUSULFAN | May 1, 2018 | Abandoned |
Array
(
[id] => 17148373
[patent_doc_number] => 11141424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => Bladder instillation composition containing chondroitin sulfate (20 mg/ml), hyaluronic acid (16 mg/ml) and a phosphate buffer (pH 6.1 to 7.9) with increased storage stability for treating cystitis
[patent_app_type] => utility
[patent_app_number] => 16/612011
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18923
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612011
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612011 | Bladder instillation composition containing chondroitin sulfate (20 mg/ml), hyaluronic acid (16 mg/ml) and a phosphate buffer (pH 6.1 to 7.9) with increased storage stability for treating cystitis | May 1, 2018 | Issued |
Array
(
[id] => 13383455
[patent_doc_number] => 20180243269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => FORAZOLINES, COMPOSITIONS THEREOF AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/968456
[patent_app_country] => US
[patent_app_date] => 2018-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15968456
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/968456 | Forazolines, compositions thereof and uses thereof | Apr 30, 2018 | Issued |
Array
(
[id] => 13519447
[patent_doc_number] => 20180311266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2
[patent_app_type] => utility
[patent_app_number] => 15/966238
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15966238
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/966238 | COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 | Apr 29, 2018 | Abandoned |
Array
(
[id] => 15863121
[patent_doc_number] => 20200138964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => TERTIARY AMINE COMPOUND OR IMINE COMPOUND-POLYMER CONJUGATE AND PRODUCTION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/608677
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608677
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608677 | TERTIARY AMINE COMPOUND OR IMINE COMPOUND-POLYMER CONJUGATE AND PRODUCTION METHOD THEREFOR | Apr 24, 2018 | Abandoned |
Array
(
[id] => 17280859
[patent_doc_number] => 11197872
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs)
[patent_app_type] => utility
[patent_app_number] => 16/606485
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 33
[patent_no_of_words] => 5800
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606485
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606485 | Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs) | Apr 19, 2018 | Issued |
Array
(
[id] => 13504647
[patent_doc_number] => 20180303866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => VETERINARY COMPOSITIONS FOR USE IN TREATING MASTITIS, AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 15/956849
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15956849
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/956849 | Veterinary compositions for use in treating mastitis, and associated methods | Apr 18, 2018 | Issued |
Array
(
[id] => 17586531
[patent_doc_number] => 11324773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Compounds, compositions and methods for inhibiting a pathogen and/or modifying mucus
[patent_app_type] => utility
[patent_app_number] => 16/500755
[patent_app_country] => US
[patent_app_date] => 2018-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 24602
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500755
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500755 | Compounds, compositions and methods for inhibiting a pathogen and/or modifying mucus | Apr 9, 2018 | Issued |
Array
(
[id] => 16312701
[patent_doc_number] => 20200291439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => PROCESS FOR MAKING PULLULAN
[patent_app_type] => utility
[patent_app_number] => 16/604550
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604550
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604550 | Process for making pullulan | Apr 8, 2018 | Issued |
Array
(
[id] => 15828505
[patent_doc_number] => 20200129534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => TREATMENT OF INFLAMMATORY BOWEL DISEASES WITH 2'-FUCOSYLLACTOSE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/500935
[patent_app_country] => US
[patent_app_date] => 2018-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500935 | TREATMENT OF INFLAMMATORY BOWEL DISEASES WITH 2'-FUCOSYLLACTOSE COMPOUNDS | Apr 6, 2018 | Abandoned |
Array
(
[id] => 16998344
[patent_doc_number] => 11077126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Use of carrimycin and pharmaceutically acceptable salts of carrimycin in manufacturing medicament for treating and/or preventing tumor
[patent_app_type] => utility
[patent_app_number] => 16/500967
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23989
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500967
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500967 | Use of carrimycin and pharmaceutically acceptable salts of carrimycin in manufacturing medicament for treating and/or preventing tumor | Apr 4, 2018 | Issued |
Array
(
[id] => 18558689
[patent_doc_number] => 11723914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Nitric oxide-releasing polyaminoglycosides as biodegradable antibacterial scaffolds and methods pertaining thereto
[patent_app_type] => utility
[patent_app_number] => 16/497696
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 23
[patent_no_of_words] => 16934
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497696 | Nitric oxide-releasing polyaminoglycosides as biodegradable antibacterial scaffolds and methods pertaining thereto | Mar 27, 2018 | Issued |
Array
(
[id] => 13986369
[patent_doc_number] => 20190062342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => NOVEL ANTIBACTERIAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/934430
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15934430
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/934430 | NOVEL ANTIBACTERIAL AGENTS | Mar 22, 2018 | Abandoned |
Array
(
[id] => 13440691
[patent_doc_number] => 20180271888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => COMPOSITIONS AND METHODS FOR PARKINSON'S DISEASE THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/933215
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15933215
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/933215 | COMPOSITIONS AND METHODS FOR PARKINSON'S DISEASE THERAPY | Mar 21, 2018 | Abandoned |
Array
(
[id] => 16523734
[patent_doc_number] => 20200397814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => CARBOHYDRATE COMPOSITION FOR DIALYSIS
[patent_app_type] => utility
[patent_app_number] => 15/780214
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780214
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780214 | Carbohydrate composition for dialysis | Mar 21, 2018 | Issued |
Array
(
[id] => 13490095
[patent_doc_number] => 20180296590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => TREATMENT OF MYELOSUPPRESSION
[patent_app_type] => utility
[patent_app_number] => 15/923470
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923470
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/923470 | TREATMENT OF MYELOSUPPRESSION | Mar 15, 2018 | Abandoned |
Array
(
[id] => 15342807
[patent_doc_number] => 20200009295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => Functionalized Scaffold To Promote Meniscus Repair
[patent_app_type] => utility
[patent_app_number] => 16/494746
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494746 | Functionalized Scaffold To Promote Meniscus Repair | Mar 15, 2018 | Abandoned |
Array
(
[id] => 13531877
[patent_doc_number] => 20180317481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => SURFACE STERILISATION BY MISTING WITH A BIOFLAVANOID SOLUTION
[patent_app_type] => utility
[patent_app_number] => 15/916465
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15916465
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/916465 | SURFACE STERILISATION BY MISTING WITH A BIOFLAVANOID SOLUTION | Mar 8, 2018 | Abandoned |
Array
(
[id] => 15320849
[patent_doc_number] => 20200000754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => NOVEL VISCOELASTIC SOLUTION AND USE THEREOF IN RHUMATOLOGY
[patent_app_type] => utility
[patent_app_number] => 16/492218
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492218
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492218 | Viscoelastic solution and use thereof in rhumatology | Mar 5, 2018 | Issued |